HOME › DRUGS › PERFLUTREN
ACTIVE SUBSTANCE / INN

PERFLUTREN

Brand name(s): Luminity, DEFINITY, DEFINITY RT, Optison
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Echocardiography
NDA021064
ACTIVE SUBSTANCE
Perflutren
REGULATORS
FDA · EMA
SPONSORS / MAH
LANTHEUS MEDCL, Lantheus EU Limited, GE Healthcare AS
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DEFINITYNDA021064LANTHEUS MEDCLPrescription
DEFINITY RTNDA021064LANTHEUS MEDCLPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LuminityLantheus EU LimitedAuthorised20/09/2006Echocardiography
OptisonGE Healthcare ASAuthorised17/05/1998Echocardiography

FULL INTELLIGENCE ON PERFLUTREN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →